Skip to main content
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. — Investor Relations & Filings

Ticker · AQST ISIN · US03843E1047 US Manufacturing
Filings indexed 607 across all filing types
Latest filing 2018-09-05 Director's Dealing
Country US United States of America
Listing US AQST

About Aquestive Therapeutics, Inc.

https://aquestive.com/

Aquestive Therapeutics is a pharmaceutical company that develops and commercializes medicines using its proprietary PharmFilm® technology. This oral film drug delivery system provides a non-invasive and convenient alternative to conventional therapies, such as injections, by enabling the oral administration of complex molecules. The company's development pipeline is focused on addressing unmet medical needs in central nervous system (CNS) disorders and severe allergic reactions. Key product candidates include Anaphylm™, an epinephrine sublingual film for the emergency treatment of anaphylaxis, and Libervant®, a diazepam buccal film for the management of seizure clusters.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2018-09-05 English
FORM 4
Director's Dealing
2018-09-05 English
10-Q
Interim / Quarterly Report Q2 2018
2018-09-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K, which is a current report filed with the SEC to announce major events that shareholders should know about. The text includes announcements of financial results for the second quarter ended June 30, 2018, and an FDA tentative approval of a drug. The document references press releases attached as exhibits but does not contain detailed financial statements or comprehensive financial analysis itself. The length is about 4800 characters, which is relatively short and consistent with a current report rather than a full quarterly or annual report. The document is primarily an announcement of events and financial results, not the full financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2018-09-04 English
FORM 4
Director's Dealing
2018-08-18 English
FORM 4
Director's Dealing
2018-08-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.